Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody

Abstract Background This study aimed to describe the clinical characteristics and analyze the poor prognostic factors in patients with anti-MDA5 dermatomyositis. Methods A total of 126 adults with anti-MDA5 dermatomyositis were enrolled in this retrospective study. Information on survival time, caus...

Full description

Bibliographic Details

Published in:	Arthritis Research & Therapy
Main Authors:	Huyan Wang, Xin Chen, Yan Du, Lihua Wang, Qiyuan Wang, Huaxiang Wu, Lei Liu, Jing Xue
Format:	Article
Language:	English
Published:	BMC 2023-07-01
Subjects:	Dermatomyositis Anti-MDA5 antibody Anti-Ro52 antibody Rapidly progressive interstitial lung disease Prognosis
Online Access:	https://doi.org/10.1186/s13075-023-03100-z